BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31950286)

  • 1. Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.
    Mody MD; Saba NF
    Curr Treat Options Oncol; 2020 Jan; 21(1):4. PubMed ID: 31950286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paranasal sinus carcinoma--diagnosis, treatment, and prognosis.
    Carrau RL; Myers EM; Johnson JT
    Oncology (Williston Park); 1992 Jan; 6(1):43-50; discussion 55-6. PubMed ID: 1531603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
    Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
    J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.
    Orlandi E; Cavalieri S; Granata R; Nicolai P; Castelnuovo P; Piazza C; Schreiber A; Turri-Zanoni M; Quattrone P; Miceli R; Infante G; Sessa F; Facco C; Calareso G; Iacovelli NA; Mattavelli D; Paderno A; Resteghini C; Locati LD; Licitra L; Bossi P
    Laryngoscope; 2020 Apr; 130(4):857-865. PubMed ID: 31369156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer.
    López F; Lund VJ; Suárez C; Snyderman CH; Saba NF; Robbins KT; Vander Poorten V; Strojan P; Mendenhall WM; Rinaldo A; Ferlito A
    Adv Ther; 2017 Oct; 34(10):2181-2198. PubMed ID: 28871554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma.
    Amit M; Na'ara S; Hanna EY
    Curr Oncol Rep; 2018 Feb; 20(2):10. PubMed ID: 29492677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in the management of sinonasal mucosal melanoma.
    Crippen MM; Kılıç S; Eloy JA
    Curr Opin Otolaryngol Head Neck Surg; 2018 Feb; 26(1):52-57. PubMed ID: 29095708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single modality and multimodality treatment of nasal and paranasal sinuses cancer: a single institution experience of 229 patients.
    Guntinas-Lichius O; Kreppel MP; Stuetzer H; Semrau R; Eckel HE; Mueller RP
    Eur J Surg Oncol; 2007 Mar; 33(2):222-8. PubMed ID: 17127030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinonasal mucosal melanoma: A 44-case study and literature analysis.
    Dréno M; Georges M; Espitalier F; Ferron C; Charnolé A; Dréno B; Malard O
    Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):237-242. PubMed ID: 28442409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical study of multimodal treatment for orbital organ preservation in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinus.
    Chen NX; Chen L; Wang JL; Wang JY; Yan F; Ma L; Zhang XX
    Jpn J Clin Oncol; 2016 Aug; 46(8):727-34. PubMed ID: 27207888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paranasal sinus cancer.
    Bossi P; Farina D; Gatta G; Lombardi D; Nicolai P; Orlandi E
    Crit Rev Oncol Hematol; 2016 Feb; 98():45-61. PubMed ID: 26520459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer.
    Licitra L; Resteghini C; Bossi P
    Adv Otorhinolaryngol; 2020; 84():78-86. PubMed ID: 32731241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paranasal sinus cancer: caveats and controversies.
    Waldron J; Witterick I
    World J Surg; 2003 Jul; 27(7):849-55. PubMed ID: 14509518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sinonasal tract malignancies : a 14-year single institution experience].
    Schröck A; Göke F; van Bremen T; Kirsten R; Jakob M; Ehrenberg T; Kühnemund M; Gerstner A; Eichhorn KW
    HNO; 2012 Dec; 60(12):1041-6. PubMed ID: 23202858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinonasal malignancy: presentation and outcomes.
    Mahalingappa YB; Khalil HS
    J Laryngol Otol; 2014 Jul; 128(7):654-7. PubMed ID: 25075949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of sinonasal malignancies invading the orbit-orbital exenteration versus preservation of the orbit plus radiotherapy.
    Safi AF; Behn L; Rothamel D; Guntinas-Lichius O; Beutner D; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2017 Feb; 45(2):258-261. PubMed ID: 28011179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and survival outcomes of sinonasal verrucous carcinoma in the United States.
    Alonso JE; Han AY; Kuan EC; Suh JD; John MAS
    Laryngoscope; 2018 Mar; 128(3):651-656. PubMed ID: 28865078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
    Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
    Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management of emerging sinonasal malignancies.
    Contrera KJ; Woody NM; Rahman M; Sindwani R; Burkey BB
    Head Neck; 2020 Aug; 42(8):2202-2212. PubMed ID: 32212360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sinunasal Tumors].
    Arens C
    Laryngorhinootologie; 2016 Apr; 95(4):270-89; quiz 290-1. PubMed ID: 27058141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.